Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
ImmunityBio, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Anktiva® (nogapendekin alfa inbakicept) in combination with BCG for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary disease.

ImmunityBio, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application (sBLA) for Anktiva® (nogapendekin alfa inbakicept) in combination with BCG for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with papillary disease.

老虎证券老虎证券2026/05/20 00:56
Show original
The FDA has also set the Prescription Drug User Fee Act (PDUFA) target date for this application—January 6, 2027. This sBLA submission is based on positive data from a pivotal phase 2/3 clinical trial. The study evaluated the efficacy and safety of Anktiva in combination with BCG in BCG-unresponsive NMIBC patients. Data show that this combination therapy significantly improved the complete response rate and demonstrated good tolerability. If approved, Anktiva combined with BCG will provide an important new treatment option for this patient population with limited therapeutic choices. The PDUFA date marks the FDA’s target timeline for completing its review, but the final decision may come before or after this date.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Under continuous pressure from inflation and interest rate hike concerns, US Treasury sell-off intensifies; 30-year yield once surpassed 5.6%, hitting a more than 24-year high

U.S. long-term Treasury yields continued to rise on Tuesday, extending the recent sharp upward trend.

智通财经•2026/09/29 22:31

The US releases the final batch of strategic oil reserves, up to 40 million barrels, urging Europe to follow suit.

This is the final batch of the 172 million barrels of reserves released by the United States in this round; after this release, the U.S. Strategic Petroleum Reserve will drop to its lowest level since 1982, approaching legal and operational red lines. Meanwhile, the U.S. Secretary of Energy criticized some European countries for releasing far less than expected, urging them to fulfill their commitments. Currently, gasoline and diesel prices in the U.S. remain high, and less than two months remain until the midterm elections. On Tuesday, WTI crude oil futures fell by 3.95%.

华尔街见闻•2026/09/29 22:26